1,2,5-Triphenyltetrazol-1-ium

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1,2,5-Triphenyltetrazol-1-ium
• 化学式: C19H15N4+
• 分子量: 299.3
• InChiKey: GDLNKECVZZJSBY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.8
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  34.6
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Compositions And Methods For Treating Ischemia And Ischemia-Reperfusion Injury
  申请人：Ischemix LLC

  公开号：US20160264622A1

  公开（公告）日：2016-09-15

  The present invention relates to compositions comprising a substantially pure compound represented by Structural Formula I: and methods of using such compounds to activate cytoprotective kinases. The values and preferred values of the variables in Structural Formula I are defined herein.

  本发明涉及包含由结构式I代表的基本纯化合物的组合物，以及利用这些化合物来激活细胞保护激酶的方法。结构式I中变量的值和首选值在本文中有定义。
• METHOD AND DEVICE FOR THE DETECTION OF SULPHUR CONTAINING SPECIES
  申请人：Fallis Ian

  公开号：US20130224873A1

  公开（公告）日：2013-08-29

  A method is provided for detecting sulphur-containing species (such as thiophosphorous esters, in particular phosphorylating agents), in which a suspected sulphur-containing species is brought into contact with a tetrazolium compound in the presence of base, typically at a pH of at least 8. A device, kit and tetrazolium compounds for use in such a method are also disclosed.

  提供了一种用于检测含硫物质（如噻磷酯酯，特别是磷酰化剂）的方法，其中将疑似含硫物质与四唑化合物在碱的存在下接触，通常在至少为8的pH下。还公开了用于此类方法的装置、工具包和四唑化合物。
• Primary N-hydroxylamines
  申请人：The Regents of the University of California

  公开号：US20030153535A1

  公开（公告）日：2003-08-14

  The invention provides pharmaceutical compositions comprising primary N-hydroxylamines and related therapeutic, prophylactic, diagnostic and screening methods. The pharmaceutical compositions generally comprise a pharmaceutical composition comprising an orally administrable effective unit solid dosage of a primary N-hydroxylamine or a pharmaceutically acceptable salt thereof and substantially free of a nitrone corresponding to the hydroxylamine.

  这项发明提供了含有主要N-羟胺及相关治疗、预防、诊断和筛选方法的药物组合物。这些药物组合物通常包括一种含有主要N-羟胺或其在药学上可接受的盐的口服可有效单位固体剂量的药物组合物，并且基本上不含与羟胺对应的亚硝基羟胺。
• [EN] NEW METAL CARBONYL COMPLEXES OF CURCUMIN DERIVATIVES, THEIR SYNTHESIS AND THEIR USES IN THERAPEUTIC APPLICATION<br/>[FR] NOUVEAUX COMPLEXES MÉTAL CARBONYLE DE DÉRIVÉS DE CURCUMINE, LEUR SYNTHÈSE ET LEURS APPLICATIONS DANS LE CHAMP THÉRAPEUTIQUE
  申请人：UNIV PARIS CURIE

  公开号：WO2012076696A1

  公开（公告）日：2012-06-14

  The present invention relates to new metal carbonyl complexes of curcumin derivatives, their synthesis and their uses in therapeutic application.

  本发明涉及姜黄素衍生物新金属羰基配合物、它们的合成以及它们在治疗应用中的用途。
• Tetrahydrobenzothiazole analogues as neuroprotective agents
  申请人：——

  公开号：US20040067991A1

  公开（公告）日：2004-04-08

  This invention relates generally to tetrahydrobenzothiazole analogues and tetrahydrobenzooxyzole analogues, to pharmaceutical compositions which include these compounds and a pharmaceutically acceptable carrier, and to methods of treatment using these compounds. The invention also encompasses pharmaceutically acceptable esters, amides, and salts of such compounds. The invention further provides a method of reducing or delaying apoptosis in a population of cells, comprising contacting the population of cells with a tetrahydrobenzothiazole analogue or a tetrahydrobenzooxyzole analogue, thereby reducing or delaying apoptosis in the population of cells.

  本发明涉及四氢苯并噻唑类似物和四氢苯并噁唑类似物，包括这些化合物和药物可接受载体的制药组合物，以及使用这些化合物的治疗方法。本发明还包括这些化合物的药物可接受酯，酰胺和盐。本发明还提供一种减少或延迟细胞群中凋亡的方法，包括将四氢苯并噻唑类似物或四氢苯并噁唑类似物与细胞群接触，从而减少或延迟细胞群中的凋亡。